Precision System Science Co., Ltd. (7707.T)

JPY 227.0

(-0.44%)

Total Liabilities Summary of Precision System Science Co., Ltd.

  • Precision System Science Co., Ltd.'s latest annual total liabilities in 2023 was 2.25 Billion JPY , down -50.35% from previous year.
  • Precision System Science Co., Ltd.'s latest quarterly total liabilities in 2023 FY was 2.25 Billion JPY , down -50.35% from previous quarter.
  • Precision System Science Co., Ltd. reported annual total liabilities of 4.53 Billion JPY in 2022, down -7.32% from previous year.
  • Precision System Science Co., Ltd. reported annual total liabilities of 4.89 Billion JPY in 2021, down -1.84% from previous year.
  • Precision System Science Co., Ltd. reported quarterly total liabilities of 2.25 Billion JPY for 2023 Q4, up 3.49% from previous quarter.
  • Precision System Science Co., Ltd. reported quarterly total liabilities of 2.17 Billion JPY for 2023 Q3, down -47.85% from previous quarter.

Annual Total Liabilities Chart of Precision System Science Co., Ltd. (2023 - 2007)

Historical Annual Total Liabilities of Precision System Science Co., Ltd. (2023 - 2007)

Year Total Liabilities Total Liabilities Growth
2023 2.25 Billion JPY -50.35%
2022 4.53 Billion JPY -7.32%
2021 4.89 Billion JPY -1.84%
2020 4.99 Billion JPY 135.83%
2019 2.11 Billion JPY 38.54%
2018 1.52 Billion JPY -16.88%
2017 1.83 Billion JPY -10.51%
2016 2.05 Billion JPY -14.03%
2015 2.38 Billion JPY -1.29%
2014 2.41 Billion JPY -18.64%
2013 2.97 Billion JPY -8.44%
2012 3.24 Billion JPY 64.83%
2011 1.97 Billion JPY 13.19%
2010 1.74 Billion JPY -6.82%
2009 1.86 Billion JPY 19.44%
2008 1.56 Billion JPY -13.15%
2007 1.8 Billion JPY 0.0%

Peer Total Liabilities Comparison of Precision System Science Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Shin Nippon Biomedical Laboratories, Ltd. 42.14 Billion JPY 94.652%
DNA Chip Research Inc. 250.12 Million JPY -801.034%
Cosmo Bio Company,Limited 1.84 Billion JPY -22.019%
H.U. Group Holdings, Inc. 152.84 Billion JPY 98.526%
FALCO HOLDINGS Co., Ltd. 10.39 Billion JPY 78.322%
BML, Inc. 40.85 Billion JPY 94.483%
Human Metabolome Technologies, Inc. 656.68 Million JPY -243.191%